OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
48
Results
Show all
Save search
Copy query
Show results for
Unknown
(48)
Publication Date
Release Date
2018
(29)
2021
(6)
2025
(4)
2022
(4)
2023
(2)
2024
(1)
2016
(1)
2010
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
Not available
S-EPMC5906131
|
biostudies-literature
Cite
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Not available
S-EPMC5959730
|
biostudies-literature
Cite
Temperature measurement of Quark-Gluon plasma at different stages.
Not available
S-EPMC12521530
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.
Not available
S-EPMC6370347
|
biostudies-literature
Cite
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Not available
S-EPMC6002769
|
biostudies-literature
Cite
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Not available
S-EPMC6326181
|
biostudies-literature
Cite
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
Not available
S-EPMC5916795
|
biostudies-literature
Cite
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Not available
S-EPMC6075733
|
biostudies-literature
Cite
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Not available
S-EPMC5892207
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets